The company's Profit Recovery and Growth Plan drove gross margin expansion of 140 basis points to 76.4% and adjusted operating margin improvement of 360 basis points to 15.0%. Led by the "Beauty Reimagined" strategy, organic sales for Fragrance rose double-digits in the first nine months of fiscal 2026, while three of four regions grew, with Mainland China outperforming prestige beauty to gain share.
Cyborg Score Rationale
Q3 2026 delivered exceptional results with EPS of $0.91 beating forecast by 40% and revenue at $3.71B exceeding expectations, driving a 6% stock surge. The company expanded its restructuring program targeting up to 10,000 total position reductions with expected annual savings climbing to as much as $1.20 billion. However, tariff-related headwinds are expected to impact FY2026 profitability by approximately $100 million, with Middle East disruptions expected to have a dilutive impact of $0.07 to full-year EPS.
Top Insights
(May 2026) Strong Q3 2026 earnings beat with 40% EPS surprise and 76.4% gross margins reflecting operational efficiency gains from restructuring efforts
(May 2026) Fragrance category organic sales grew double-digits across all regions, with Mainland China showing mid-single-digit organic growth for third consecutive quarter
(May 2026) Raised FY2026 adjusted EPS guidance to $2.35–$2.45 and offered preliminary FY2027 guidance of 3–5% net sales growth with 12.5–13.0% adjusted operating margin
(May 2026) Expanded restructuring program targeting up to 10,000 position reductions with potential annual savings of $1.20 billion, offsetting ~$100M tariff impact
Named Competitors
Skincare & Makeup — Leading European prestige beauty and fragrance conglomerate
Dior Beauty — Luxury fashion and beauty holding with major prestige beauty brands
CoverGirl, Clairol — Global beauty company with heritage prestige and mass-market brands
Shiseido — Japanese prestige beauty and skincare leader